In 2024, the global musculo-skeletal system medicine sales show Germany leading with $29.01 million, followed closely by South Korea at $26.21 million. Austria and Finland remain at the lower spectrum with $2.01 million and $2.03 million, respectively. Notably, Germany and South Korea posted year-on-year growths of 2.26% and 2.25%, respectively, indicating stable markets. Conversely, New Zealand experienced a significant decline of -5.94%. Noteworthy growths were observed in Latvia (4.63%) and Estonia (5.95%), whereas Mexico and Chile faced declines of -2.37% and -2.6%, respectively.
Looking ahead, there are several key trends to watch in the global musculo-skeletal system medicine sales market. Increasing investments in healthcare innovations, an aging population in developed countries, and growing awareness for treatment options in emerging markets may drive growth. Additionally, advancements in personalized medicine and biologics might offer new growth avenues, particularly in regions with currently lower market shares like Latvia and Estonia.
Top countries in Musculo-Skeletal System Medicine Sales Share by Country (Million US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.01 | 2023 | +1.26% | +2.26% | View data |
| 2 | 2 South Korea | 26.21 | 2023 | +2.43% | +2.25% | View data |
| 3 | 3 Australia | 7.76 | 2023 | +2.12% | +4.14% | View data |
| 4 | 4 Switzerland | 7.69 | 2023 | +5.08% | +1.18% | View data |
| 5 | 5 Croatia | 6.48 | 2023 | +1.89% | -0.28% | View data |
| 6 | 6 Belgium | 4.3 | 2023 | -0.63% | -1.92% | View data |
| 7 | 7 Sweden | 3.47 | 2023 | +4.18% | +0.29% | View data |
| 8 | 8 Portugal | 3.15 | 2023 | -0.16% | -0.48% | View data |
| 9 | 9 Chile | 2.82 | 2023 | +11.94% | -2.6% | View data |
| 10 | 10 Slovakia | 2.29 | 2023 | +3.06% | +6.24% | View data |
